Zaloguj się

Gotowe bibliografie tematyczne / Phosphoribosyltransferase / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Phosphoribosyltransferase.

Artykuły w czasopismach na temat „Phosphoribosyltransferase”

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 4 lutego 2022

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Phosphoribosyltransferase”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Fateev, Ilja V., Ekaterina V. Sinitsina, Aiguzel U. Bikanasova, Maria A. Kostromina, Elena S. Tuzova, Larisa V. Esipova, Tatiana I. Muravyova, Alexei L. Kayushin, Irina D. Konstantinova i Roman S. Esipov. "Thermophilic phosphoribosyltransferases Thermus thermophilus HB27 in nucleotide synthesis". Beilstein Journal of Organic Chemistry 14 (21.12.2018): 3098–105. http://dx.doi.org/10.3762/bjoc.14.289.

Pełny tekst źródła

Streszczenie:

Phosphoribosyltransferases are the tools that allow the synthesis of nucleotide analogues using multi-enzymatic cascades. The recombinant adenine phosphoribosyltransferase (TthAPRT) and hypoxanthine phosphoribosyltransferase (TthHPRT) from Thermus thermophilus HB27 were expressed in E.coli strains and purified by chromatographic methods with yields of 10–13 mg per liter of culture. The activity dependence of TthAPRT and TthHPRT on different factors was investigated along with the substrate specificity towards different heterocyclic bases. The kinetic parameters for TthHPRT with natural substrates were determined. Two nucleotides were synthesized: 9-(β-D-ribofuranosyl)-2-chloroadenine 5'-monophosphate (2-Сl-AMP) using TthAPRT and 1-(β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine-4-one 5'-monophosphate (Allop-MP) using TthНPRT.

Style APA, Harvard, Vancouver, ISO itp.

2

Aklujkar, Muktak. "Two ATP phosphoribosyltransferase isozymes of Geobacter sulfurreducens contribute to growth in the presence or absence of histidine and under nitrogen fixation conditions". Canadian Journal of Microbiology 57, nr 7 (lipiec 2011): 547–58. http://dx.doi.org/10.1139/w11-047.

Pełny tekst źródła

Streszczenie:

Bacteria of the Geobacter clade possess two distinct ATP phosphoribosyltransferases encoded by hisGL and hisGS+hisZ to catalyze the first reaction of histidine biosynthesis. This very unusual redundancy was investigated by mutational analysis. The hisGL, hisGS, and hisZ genes of Geobacter sulfurreducens were deleted, effects on growth and histidine biosynthesis gene expression were evaluated, and deficiencies were complemented with plasmid-borne genes. Both hisGL and hisGS+hisZ encode functional ATP phosphoribosyltransferases. However, deletion of hisGL resulted in no growth defect, whereas deletion of hisGS delayed growth when histidine was not provided. Both deletions increased hisZ transcript abundance, and both ΔhisGS and ΔhisZ mutations increased hisGL transcript abundance. Growth with HisGL alone (due to deletion of either hisGS or hisZ) was better under nitrogen fixation conditions than when ammonium was provided. Deletion of hisZ caused growth defects under all conditions tested, with or without exogenous sources of histidine, with different patterns of histidine biosynthesis gene expression under each condition. Taken together, the data indicate that G. sulfurreducens depends primarily on the HisGSZ isozyme as an ATP phosphoribosyltransferase in histidine biosynthesis, and for other functions when histidine is available; however, HisGL also functions as ATP phosphoribosyltransferase, particularly during nitrogen fixation.

Style APA, Harvard, Vancouver, ISO itp.

3

Sauer, Jørgen, i Per Nygaard. "Expression of the Methanobacterium thermoautotrophicum hpt Gene, Encoding Hypoxanthine (Guanine) Phosphoribosyltransferase, in Escherichia coli". Journal of Bacteriology 181, nr 6 (15.03.1999): 1958–62. http://dx.doi.org/10.1128/jb.181.6.1958-1962.1999.

Pełny tekst źródła

Streszczenie:

ABSTRACT The hpt gene from the archaeon Methanobacterium thermoautotrophicum, encoding hypoxanthine (guanine) phosphoribosyltransferase, was cloned by functional complementation into Escherichia coli. The hpt-encoded amino acid sequence is most similar to adenine phosphoribosyltransferases, but the encoded enzyme has activity only with hypoxanthine and guanine. The synthesis of the recombinant enzyme is apparently limited by the presence of the rare arginine codons AGA and AGG and the rare isoleucine AUA codon on the hpt gene. The recombinant enzyme was purified to apparent homogeneity.

Style APA, Harvard, Vancouver, ISO itp.

4

Bollée, Guillaume, Jérôme Harambat, Albert Bensman, Bertrand Knebelmann, Michel Daudon i Irène Ceballos-Picot. "Adenine Phosphoribosyltransferase Deficiency". Clinical Journal of the American Society of Nephrology 7, nr 9 (14.06.2012): 1521–27. http://dx.doi.org/10.2215/cjn.02320312.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Kadziola, A., K. S. Jensen, A. Mølgaard, J. C. N. Poulsen i K. F. Jensen. "Sulfolobus solfataricusadenine phosphoribosyltransferase". Acta Crystallographica Section A Foundations of Crystallography 67, a1 (22.08.2011): C786—C787. http://dx.doi.org/10.1107/s0108767311080093.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Munagala, Narsimha, Anne E. Sarver i Ching C. Wang. "Converting the Guanine Phosphoribosyltransferase fromGiardia lambliato a Hypoxanthine-guanine Phosphoribosyltransferase". Journal of Biological Chemistry 275, nr 47 (6.09.2000): 37072–77. http://dx.doi.org/10.1074/jbc.m007239200.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

OLIVEIRA, DENILSON F., HELVÉCIO M. DOS SANTOS JÚNIOR, ALEXANDRO S. NUNES, VICENTE P. CAMPOS, RENATA S. C. DE PINHO i GIOVANNA C. GAJO. "Purification and identification of metabolites produced by Bacillus cereus and B. subtilis active against Meloidogyne exigua, and their in silico interaction with a putative phosphoribosyltransferase fromM. incognita". Anais da Academia Brasileira de Ciências 86, nr 2 (czerwiec 2014): 525–38. http://dx.doi.org/10.1590/0001-3765201402412.

Pełny tekst źródła

Streszczenie:

To contribute to the development of products to controlMeloidogyne exigua, the bacteria Bacillus cereus and B. subtilis were cultivated in liquid medium to produce metabolites active against this plant-parasitic nematode. Fractionation of the crude dichloromethane extracts obtained from the cultures afforded uracil, 9H-purine and dihydrouracil. All compounds were active against M. exigua, the latter being the most efficient. This substance presented a LC50 of 204 µg/mL against the nematode, while a LC50 of 260 µg/mL was observed for the commercial nematicide carbofuran. A search for protein-ligand complexes in which the ligands were structurally similar to dihydrouracil resulted in the selection of phosphoribosyltransferases, the sequences of which were used in an in silico search in the genome of M. incognita for a similar sequence of amino acids. The resulting sequence was modelled and dihydrouracil and 9H-purine were inserted in the active site of this putative phosphoribosyltransferase resulting in protein-ligand complexes that underwent molecular dynamics simulations. Calculation of the binding free-energies of these complexes revealed that the dissociation constant of dihydrouracil and 9H-purine to this protein is around 8.3 x 10-7 and 1.6 x 10-6 M, respectively. Consequently, these substances and the putative phosphoribosyltransferase are promising for the development of new products to control M. exigua.

Style APA, Harvard, Vancouver, ISO itp.

8

Jardim, Armando, Susan E. Bergeson, Sarah Shih, Nicola Carter, Randall W. Lucas, Gilles Merlin, Peter J. Myler, Kenneth Stuart i Buddy Ullman. "Xanthine Phosphoribosyltransferase fromLeishmania donovani". Journal of Biological Chemistry 274, nr 48 (26.11.1999): 34403–10. http://dx.doi.org/10.1074/jbc.274.48.34403.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Pittelli, Maria, Laura Formentini, Giuseppe Faraco, Andrea Lapucci, Elena Rapizzi, Francesca Cialdai, Giovanni Romano, Gloriano Moneti, Flavio Moroni i Alberto Chiarugi. "Inhibition of Nicotinamide Phosphoribosyltransferase". Journal of Biological Chemistry 285, nr 44 (19.08.2010): 34106–14. http://dx.doi.org/10.1074/jbc.m110.136739.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

OLESEN, UFFE HØGH, NINA HASTRUP i MAXWELL SEHESTED. "Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas". APMIS 119, nr 4-5 (25.03.2011): 296–303. http://dx.doi.org/10.1111/j.1600-0463.2011.02733.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Nishida, Y., i T. Miyamoto. "Simple Screening Methods for Hypoxanthine-Guanine Phosphoribosyltransferase and Adenine Phosphoribosyltransferase Deficiencies Using Dried Blood Spots on Filter Paper". Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 23, nr 5 (wrzesień 1986): 529–32. http://dx.doi.org/10.1177/000456328602300507.

Pełny tekst źródła

Streszczenie:

Simple methods for the detection of hypoxanthine-guanine phosphoribosyltransferase and/or adenine phosphoribosyltransferase deficiencies using dried filter paper blood spots were studied. Enzyme activities in the eluate from dried filter paper blood spots stored for 4 weeks at room conditions were shown to be quite stable. Autoradiographs prepared from dried filter paper blood spots and DE-81 papers soaked with enzyme reaction mixtures containing 14C-hypoxanthine and/or 14C-adenine showed sharp radioactive spots in normal subjects. No activity was evident in the cases of the Lesch-Nyhan syndrome and/or adenine phosphoribosyltransferase deficiency. The methods seem to be suitable for screening.

Style APA, Harvard, Vancouver, ISO itp.

12

CURTO, Raul, O. Eberhard VOIT i Marta CASCANTE. "Analysis of abnormalities in purine metabolism leading to gout and to neurological dysfunctions in man". Biochemical Journal 329, nr 3 (1.02.1998): 477–87. http://dx.doi.org/10.1042/bj3290477.

Pełny tekst źródła

Streszczenie:

A modelling approach is used to analyse diseases associated with purine metabolism in man. The specific focus is on deficiencies in two enzymes, hypoxanthine:guanine phosphoribosyltransferase and adenylosuccinate lyase. These deficiencies can lead to a number of symptoms, including neurological dysfunctions and mental retardation. Although the biochemical mechanisms of dysfunctions associated with adenylosuccinate lyase deficiency are not completely understood, there is at least general agreement in the literature about possible causes. Simulations with our model confirm that accumulation of the two substrates of the enzyme can lead to significant biochemical imbalance. In hypoxanthine:guanine phosphoribosyltransferase deficiency the biochemical mechanisms associated with neurological dysfunctions are less clear. Model analyses support some old hypotheses but also suggest new indicators for possible causes of neurological dysfunctions associated with this deficiency. Hypoxanthine:guanine phosphoribosyltransferase deficiency is known to cause hyperuricaemia and gout. We compare the relative importance of this deficiency with other known causes of gout in humans. The analysis suggests that defects in the excretion of uric acid are more consequential than defects in uric acid synthesis such as hypoxanthine:guanine phosphoribosyltransferase deficiency.

Style APA, Harvard, Vancouver, ISO itp.

13

Vos, Siska, John de Jersey i Jennifer L. Martin. "Crystal Structure ofEscherichia coliXanthine Phosphoribosyltransferase†". Biochemistry 36, nr 14 (kwiecień 1997): 4125–34. http://dx.doi.org/10.1021/bi962640d.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Takahashi, Ryo, Shota Nakamura, Takuya Yoshida, Yuji Kobayashi i Tadayasu Ohkubo. "Crystallization of human nicotinamide phosphoribosyltransferase". Acta Crystallographica Section F Structural Biology and Crystallization Communications 63, nr 5 (6.04.2007): 375–77. http://dx.doi.org/10.1107/s1744309107006069.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Scapin, Giovanna, Charles Grubmeyer i James C. Sacchettini. "Crystal Structure of Orotate Phosphoribosyltransferase". Biochemistry 33, nr 6 (15.02.1994): 1287–94. http://dx.doi.org/10.1021/bi00172a001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Raman, Jayalakshmi, Chethan S. Ashok, Sujay I.N. Subbayya, Ranjith P. Anand, Senthamizh T. Selvi i Hemalatha Balaram. "Plasmodium falciparum hypoxanthine guanine phosphoribosyltransferase". FEBS Journal 272, nr 8 (29.03.2005): 1900–1911. http://dx.doi.org/10.1111/j.1742-4658.2005.04620.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

LAXDAL, THRÖSTUR, i TÓMAS Á. JÓNASSON. "Adenine Phosphoribosyltransferase Deficiency in Iceland". Acta Medica Scandinavica 224, nr 6 (24.04.2009): 621–26. http://dx.doi.org/10.1111/j.0954-6820.1988.tb19635.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Árnadóttir, Margrét. "Febuxostat in Adenosine Phosphoribosyltransferase Deficiency". American Journal of Kidney Diseases 64, nr 2 (sierpień 2014): 316. http://dx.doi.org/10.1053/j.ajkd.2014.04.026.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Torres, R. J., S. Puente, A. Menendez i N. Fernandez-Garcia. "Unapparent hypoxanthine-guanine phosphoribosyltransferase deficiency". Clinica Chimica Acta 472 (wrzesień 2017): 136–38. http://dx.doi.org/10.1016/j.cca.2017.08.002.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Harambat, Jérôme, Guillaume Bollée, Michel Daudon, Irène Ceballos-Picot i Albert Bensman. "Adenine phosphoribosyltransferase deficiency in children". Pediatric Nephrology 27, nr 4 (3.01.2012): 571–79. http://dx.doi.org/10.1007/s00467-011-2037-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Davidson, B. L., M. Pashmforoush, W. N. Kelley i T. D. Palella. "Human Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency". Journal of Biological Chemistry 264, nr 1 (styczeń 1989): 520–25. http://dx.doi.org/10.1016/s0021-9258(17)31289-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Syed, Danyal B., i Donald L. Sloan. "Orotate phosphoribosyltransferase and hypoxanthine/guanine phosphoribosyltransferase from yeast: Kinetic analysis with chromium(III) pyrophosphate". Journal of Inorganic Biochemistry 38, nr 2 (luty 1990): 127–38. http://dx.doi.org/10.1016/0162-0134(90)84021-g.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Ikeda, Kazumasa, Harudo Suzuki i Shigeki Nakagawa. "Human brain hypoxanthine guanine phosphoribosyltransferase: Structural and functional comparison with erythrocyte hypoxanthine guanine phosphoribosyltransferase". International Journal of Biochemistry 18, nr 7 (styczeń 1986): 575–81. http://dx.doi.org/10.1016/0020-711x(86)90236-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Allen, Thomas, Eugene V. Henschel, Terry Coons, Laura Cross, Joseph Conley i Buddy Ullman. "Purification and characterization of the adenine phosphoribosyltransferase and hypoxanthine-guanine phosphoribosyltransferase activities from Leishmania donovani". Molecular and Biochemical Parasitology 33, nr 3 (marzec 1989): 273–81. http://dx.doi.org/10.1016/0166-6851(89)90089-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Grubmeyer, C., E. Segura i R. Dorfman. "Active site lysines in orotate phosphoribosyltransferase." Journal of Biological Chemistry 268, nr 27 (wrzesień 1993): 20299–304. http://dx.doi.org/10.1016/s0021-9258(20)80728-5.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Tao, Wen, Charles Grubmeyer i John S. Blanchard. "Transition State Structure ofSalmonella typhimuriumOrotate Phosphoribosyltransferase†". Biochemistry 35, nr 1 (styczeń 1996): 14–21. http://dx.doi.org/10.1021/bi951898l.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Shackelford, R. E., K. Mayhall, N. M. Maxwell, E. Kandil i D. Coppola. "Nicotinamide Phosphoribosyltransferase in Malignancy: A Review". Genes & Cancer 4, nr 11-12 (30.10.2013): 447–56. http://dx.doi.org/10.1177/1947601913507576.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Foster, Alan C., William C. Zinkand i Robert Schwarcz. "Quinolinic Acid Phosphoribosyltransferase in Rat Brain". Journal of Neurochemistry 44, nr 2 (luty 1985): 446–54. http://dx.doi.org/10.1111/j.1471-4159.1985.tb05435.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Wang, Pei, Yun-Feng Guan, Wen-Lin Li, Guo-Cai Lu, Jian-Min Liu i Chao-Yu Miao. "Nicotinamide Phosphoribosyltransferase Facilitates Post-Stroke Angiogenesis". CNS Neuroscience & Therapeutics 21, nr 5 (9.03.2015): 475–77. http://dx.doi.org/10.1111/cns.12388.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Runolfsdottir, Hrafnhildur Linnet, Runolfur Palsson, Inger M. Agustsdottir, Olafur S. Indridason i Vidar O. Edvardsson. "Kidney Disease in Adenine Phosphoribosyltransferase Deficiency". American Journal of Kidney Diseases 67, nr 3 (marzec 2016): 431–38. http://dx.doi.org/10.1053/j.ajkd.2015.10.023.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Williamson, D. J., M. L. Hooper i D. W. Melton. "Mouse models of hypoxanthine phosphoribosyltransferase deficiency". Journal of Inherited Metabolic Disease 15, nr 4 (lipiec 1992): 665–73. http://dx.doi.org/10.1007/bf01799622.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Chiba, P., K. Zwiauer i M. M. Müller. "Characterization of an adenine phosphoribosyltransferase deficiency". Clinica Chimica Acta 172, nr 2-3 (marzec 1988): 141–47. http://dx.doi.org/10.1016/0009-8981(88)90318-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Campillo, Nuria, Hampapathalu A. Nagarajaram i Indira Ghosh. "Phosphoribosyltransferase superfamily: A comparative structural analysis". Journal of Molecular Modeling 7, nr 4 (maj 2001): 80–89. http://dx.doi.org/10.1007/s008940000001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Colombo, G., D. G. Ribaldone, G. P. Caviglia, A. Genazzani i C. Travelli. "P072 The involvement of extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) and Nicotinate Phosphoribosyltransferase (eNAPRT) in inflammatory bowel disease". Journal of Crohn's and Colitis 15, Supplement_1 (1.05.2021): S175—S176. http://dx.doi.org/10.1093/ecco-jcc/jjab076.201.

Pełny tekst źródła

Streszczenie:

Abstract Background Nicotinamide phosphoribosyltrasferase (NAMPT) is a pleiotropic enzyme which catalyses the first and rate-limiting step in the biosynthesis of NAD. It is present in two different forms: an intracellular form, called iNAMPT, (Chiarugi et al., 2012), and an extracellular form, eNAMPT. eNAMPT is considered an important factor for granulocyte-colony stimulating factor-(G-CSF)-induced myeloid differentiation, with paracrine and autocrine effects on different cell types (i.e. immune and cancer cells), binding TLR4. NAMPT is structurally and functionally related to the enzyme nicotinate phosphoribosyltransferase (iNAPRT), which is rate-limiting in the NAD salvage pathway that starts from nicotinic acid. The NAD biosynthetic pathways controlled by NAMPT and NAPRT are closely interconnected and can compensate for each other. Also, NAPRT is identified as an extracellular ligand (eNAMPRT) for TLR4 and a mediator of inflammation (Managò et al., 2020). Importantly, iNAMPT and eNAMPT levels are increased in several pathologies, included inflammatory bowel disease (IBD). It has been reported that serum eNAMPT levels correlate with the stage of the pathology: in an active state of the disease the levels of NAMPT are very high, however its levels are partially reduced in a remission stage (Moschen et al., 2007). Methods First, we investigated the role of eNAMPT and eNAPRT in murine IBD models (especially in DNBS and DSS model). We took into account phenotypic effect as weight loss and colon shortening, but also the reduction of mRNA of inflammatory genes with RT-PCR, tissue damage with H&E and IHC analysis and systemic and local production through colon explant. Secondly, we determined serum eNAMPT and eNAPRT levels in a cohort of adult IBD patients. Results Both eNAMPT and eNAPRT have been found elevated in 180 IBD patients, as proinflammatory marker of the pathologies. These levels are also elevated in serum and colonic explant of DSS and DNBS preclinical models, associated to an active state of the disease, as a pro-inflammatory response developed locally and systemically. Moreover, we performed ELISA analysis on sera of 100 IBD patients, eligible for anti-TNF treatment, both pediatric and adults. Serum eNAMPT levels are increased before the treatment, responsive patients verified a reduction of these levels, while no-responsive ones verified higher levels. Conclusion eNAMPT and eNAPRT could be considered pro-inflammatory markers of IBD and possible druggable targets.

Style APA, Harvard, Vancouver, ISO itp.

35

Santiago, Manuel F., i Thomas P. West. "Control of pyrimidine formation in Pseudomonas putida ATCC 17536". Canadian Journal of Microbiology 48, nr 12 (1.12.2002): 1076–81. http://dx.doi.org/10.1139/w02-110.

Pełny tekst źródła

Streszczenie:

The regulation of de novo pyrimidine biosynthesis in Pseudomonas putida ATCC 17536 by pyrimidines was explored. The pathway enzyme activities were higher in glucose-grown cells than in succinate-grown cells, indicating catabolite repression by succinate. In P. putida cells grown on succinate as a carbon source, only aspartate transcarbamoylase activity was greatly diminished by uracil supplementation. When glucose was the carbon source, orotic acid supplementation significantly decreased orotate phosphoribosyltransferase and orotidine 5'-monophosphate (OMP) decarboxylase activities. Uracil auxotrophs, deficient for dihydroorotase activity or with reduced phosphoribosyltransferase activity, were isolated. After pyrimidine limitation of both auxotrophs, the greatest derepression of enzyme activity was observed for OMP decarboxylase independent of carbon source. Orotic acid induced both phosphoribosyltransferase and decarboxylase activities in glucose-grown cells of the dihydroorotase-deficient strain. Regulation at the transcriptional level of de novo pyrimidine biosynthetic enzyme synthesis in P. putida ATCC 17536 was observed, which contrasts with previous observations.Key words: pyrimidine biosynthesis, regulation, auxotrophs, induction, Pseudomonas.

Style APA, Harvard, Vancouver, ISO itp.

36

INAGAKI, Kenjiroh, Akihiro MURAOKA, Itsuo SUEHIRO, Masatoshi FUJII, Hirohisa UENO, Tetsuya HOSOOKA, Kazuhisa KIDA i Keiji MURAKAMI. "Partial Adenine Phosphoribosyltransferase Deficiency Detected by Ureterolithiasis." Internal Medicine 37, nr 1 (1998): 69–72. http://dx.doi.org/10.2169/internalmedicine.37.69.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Bollée, Guillaume. "Adenine phosphoribosyltransferase deficiency: Leave no stone unturned". World Journal of Clinical Urology 3, nr 3 (2014): 218. http://dx.doi.org/10.5410/wjcu.v3.i3.218.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Benedetto, Bernard, Robert Madden, Alexander Kurbanov, Gregory Braden, Jonathan Freeman i George S. Lipkowitz. "Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction". American Journal of Kidney Diseases 37, nr 5 (maj 2001): e37.1-e37.4. http://dx.doi.org/10.1016/s0272-6386(05)90001-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Moggré, Gert-Jan, Myles B. Poulin, Peter C. Tyler, Vern L. Schramm i Emily J. Parker. "Transition State Analysis of Adenosine Triphosphate Phosphoribosyltransferase". ACS Chemical Biology 12, nr 10 (19.09.2017): 2662–70. http://dx.doi.org/10.1021/acschembio.7b00484.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Shi, Wuxian, Kelly S. E. Tanaka, Timothy R. Crother, Milton W. Taylor, Steven C. Almo i Vern L. Schramm. "Structural Analysis of Adenine Phosphoribosyltransferase fromSaccharomyces cerevisiae†,‡". Biochemistry 40, nr 36 (wrzesień 2001): 10800–10809. http://dx.doi.org/10.1021/bi010465h.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Bashor, Caleb, John M. Denu, Richard G. Brennan i Buddy Ullman. "Kinetic Mechanism of Adenine Phosphoribosyltransferase fromLeishmania donovani†". Biochemistry 41, nr 12 (marzec 2002): 4020–31. http://dx.doi.org/10.1021/bi0158730.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Sumi, Satoshi, Mitsuhiro Andou, Naoki Hamajima, Kiyoshi Kidouchi, Hajime Togari i Yoshiro Wada. "Uracil phosphoribosyltransferase activity in hereditary orotic aciduria". Clinica Chimica Acta 283, nr 1-2 (maj 1999): 201–3. http://dx.doi.org/10.1016/s0009-8981(99)00003-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Cho, Yoonsang, Vivek Sharma i James C. Sacchettini. "Crystal Structure of ATP Phosphoribosyltransferase fromMycobacterium tuberculosis". Journal of Biological Chemistry 278, nr 10 (2.01.2003): 8333–39. http://dx.doi.org/10.1074/jbc.m212124200.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

HOMMEL, Ulrich, Ariel LUSTIG i Kasper KIRSCHNER. "Purification and characterization of yeast anthranilate phosphoribosyltransferase". European Journal of Biochemistry 180, nr 1 (marzec 1989): 33–40. http://dx.doi.org/10.1111/j.1432-1033.1989.tb14611.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Galli, Ubaldina, Cristina Travelli, Alberto Massarotti, Gohar Fakhfouri, Reza Rahimian, Gian Cesare Tron i Armando A. Genazzani. "Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors". Journal of Medicinal Chemistry 56, nr 16 (31.05.2013): 6279–96. http://dx.doi.org/10.1021/jm4001049.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Hirsh, Sharon M., i Rodney E. Shackelford. "Nicotinamide Phosphoribosyltransferase Overexpression in Renal Cell Carcinomas". American Journal of Clinical Pathology 138, suppl 1 (1.07.2012): A107. http://dx.doi.org/10.1093/ajcp/138.suppl1.102.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Doyle, Patricia S., Jamil Kanaani i Ching C. Wang. "Hypoxanthine, Guanine, Xanthine Phosphoribosyltransferase Activity inCryptosporidium parvum". Experimental Parasitology 89, nr 1 (maj 1998): 9–15. http://dx.doi.org/10.1006/expr.1998.4263.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Ceballos-Picot, Irène, Abhijeet Saha, Nimisha Arora, Kanika Kapoor, Manpreet Kaur, Rachita Singh Dhull i Samridhi Goyal. "Adenine Phosphoribosyltransferase Deficiency Due to Novel Mutation". Kidney International Reports 4, nr 4 (kwiecień 2019): 624–28. http://dx.doi.org/10.1016/j.ekir.2018.12.004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Dahl, Tuva, Trine Ranheim, Sverre Holm, Rolf Berge, Pål Aukrust i Bente Halvorsen. "Nicotinamide phosphoribosyltransferase and lipid accumulation in macrophages". European Journal of Clinical Investigation 41, nr 10 (22.03.2011): 1098–104. http://dx.doi.org/10.1111/j.1365-2362.2011.02515.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Grolla, Ambra A., Cristina Travelli, Armando A. Genazzani i Jaswinder K. Sethi. "Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine". British Journal of Pharmacology 173, nr 14 (2.06.2016): 2182–94. http://dx.doi.org/10.1111/bph.13505.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!